Symptomtext
flublok inadvertently ordered, staff administered to patient. should have been fluzone with no reported adverse event; administration of flublok to patient younger than intended/ patient is 7 month infant and indication given as 18 years plus with no reported adverse event; Initial information received on 17-Jan-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 7 months old female patient and reporter sated that INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK] inadvertently ordered, staff administered to patient should have been INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE [FLUZONE] with no reported adverse event and administration of flublok to patient younger than intended/ patient is 7 month infant and indication given as 18 years plus with no reported adverse event. The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided. On 04-Jan-2023 the patient developed a non-serious event of flublok (dose: 0.5ml via intramuscular route, administration site and strength was unknown, batch number: UJ931AA and expiry date was unknown for prophylactic vaccination)inadvertently ordered, staff administered to patient. should have been fluzone with no reported adverse event (wrong product administered) (Latency: same day) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE and (INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE. On 04-Jan-2023 the patient developed a non-serious event of administration of flublok to patient younger than intended/ patient is 7 month infant and indication given as 18 years plus with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE and INFLUENZA USP TRIVAL A-B SUBVIRION NO PRESERVATIVE VACCINE. Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK) and INFLUENZA VACCINE TRIVALENT (FLUZONE) was not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.